Domestic and International Exchange Dynamics-YINFENG LIFE EXTENSION PROGRAM

EN丨CN

International Life Extension Research Alliance

Domestic and International Exchange Dynamics

Video Center

【The YinFeng Life Continuation Project Debuts at the 2026 Annual Meeting of the Chinese Medical Association's Medical Ethics Branch—Ethics Leading Biotech Toward Benevolent Innovation】

Yinfeng Foundation Honored as "2025 Public Welfare Donor" by Jinan Red Cross

Yinfeng Life Science Research Institute, in Collaboration with University of Science and Technology of China, Develops CryoSIM Platform, Published in Top Analytical Chemistry Journal Revolutionizing Oocyte Membrane Permeability Analysis Technology

Public Welfare Partnership: A Special Letter from the Jinan Red Cross

Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference

【The YinFeng Life Continuation Project Debuts at the 2026 Annual Meeting of the Chinese Medical Association's Medical Ethics Branch—Ethics Leading Biotech Toward Benevolent Innovation】

2026/07/22

The debut and discourse of the YinFeng Life Continuation Project not only served as an authoritative demonstration of its own ethical governance framework but also contributed practical wisdom toward establishing industry norms.

Yinfeng Foundation Honored as "2025 Public Welfare Donor" by Jinan Red Cross

2026/04/24

Looking ahead, Yinfeng Foundation will use this recognition as an opportunity to further deepen its strategic collaboration with the Jinan Red Cross, expand cooperation in areas such as life health and emergency response, and continue to empower efforts to accelerate the construction of a "new, strong, excellent, rich, beautiful, and high-quality" modern socialist strong capital city, contributing even more Yinfeng strength to this endeavor.

Yinfeng Life Science Research Institute, in Collaboration with University of Science and Technology of China, Develops CryoSIM Platform, Published in Top Analytical Chemistry Journal Revolutionizing Oocyte Membrane Permeability Analysis Technology

2026/03/04

The team successfully developed the CryoSIM platform, an intelligent microfluidics and deep learning-integrated system. This platform deeply integrates core technologies of deep learning and microfluidics to enable high-throughput, high-precision automated analysis of oocyte membrane permeability. It provides a novel technological tool for optimizing and advancing the clinical translation of oocyte cryopreservation techniques. Additionally, it offers an innovative practical paradigm for the application of artificial intelligence in low-temperature biomedicine and reproductive medicine.

Public Welfare Partnership: A Special Letter from the Jinan Red Cross

2026/02/02

On the afternoon of January 30, 2026, the Jinan Red Cross presented a letter of special significance to the Shandong Yinfeng Life Science Public Welfare Foundation (hereinafter referred to as the Yinfeng Foundation).

World’s First Achievement Highlights Brand Leadership

2026/01/19

In the future, Yinfeng Life Science Research Institute will continue to uphold its mission of "Dedicated to Medical Technology, Safeguarding Human Health." It will empower brand building with more original and pioneering scientific and technological achievements, contributing wisdom and strength to Shandong's goal of building a national regional innovation hub and promoting Chinese brands on the global stage.

Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference

2026/01/04

Currently, the ovarian tissue dual activation technology has been successfully applied in clinical practice at Beijing University of Chinese Medicine Shenzhen (Longgang) Hospital, having treated over 400 patients with a treatment success rate of 70%. Over the next three years, Shandong Yinfeng Life Science Research Institute plans to use Jinan as a center to gradually expand the transformation and application of this technological achievement nationwide.

2023-01-19

→

Aaron Drake, Chief Foreign Expert, Shandong Yinfeng Institute of Life Sciences, Happy New Year 2023!

2022-12-31

→

Yinfeng Cryogenic Medical Technology Co., Ltd. was listed on the list of "Innovative Small and Medium-sized Enterprises in Shandong Province in 2022".

2022-12-27

→

The team of Professor Zhao Gang, chairman of the Yinfeng Cryomedicine Expert Committee, and his collaborators published a report [Cryopreservation method of mouse follicles based on synergistic ice suppression effect]

In recent years, the incidence of malignant diseases (such as breast cancer and hematological diseases) among young women has increased. Although aggressive chemoradiotherapy or bone marrow transplantation can cure 90% of young women, these treatments can still damage their gonads. It can even lead to premature ovarian failure. In addition, many women who delay childbearing due to work or financial reasons are also affected by infertility.

2022-12-19

→

Newsletter | Yinfeng Low Temperature was invited to participate in the "International Conference on Health and Behavioral Science"

On December 19, 2022, the International Conference on Health and Behavioral Sciences, hosted by Shandong University of Finance and Economics, was successfully held. Yinfeng Cryogen, as a high-profile leader in the development of cryogenic medicine, was invited to attend the meeting. The conference was launched online, aiming to introduce the cutting-edge theoretical progress and benchmarking industry practice of the international medical care and health industry into our province, and provide international experience and think tank suggestions for the implementation of the "top ten industries" in our province.

2022-12-17

→

The world's first international cryogenic biomedical research system was officially launched - Yinfeng Cryo opens a new era of international cryogenic medicine exploration

On December 16, 2022, the "world's first international low-temperature biomedical research system" was officially launched. Once the news was released, it attracted the attention of many parties, including China Daily, Jinan Daily, Qilu Evening News, Qilu One Point Client Headline Channel, Today's Toutiao, Tencent News, NetEase News, Baidu News, Sina News and other mainstream media rushed to report on it.

2022-12-09

→

The first online exchange meeting for members of Yinfeng Life Extension Program was successfully held

On December 9, 2022, Yinfeng Life Extension Program launched the first member online exchange meeting to build a bridge to promote communication among members. This conference will have a comprehensive understanding of the new base, scientific research system and content of the life extension program, and start a scientific and technological journey through time and space for everyone.